These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6591925)

  • 1. In vitro susceptibility of Salmonella strains to cefotetan and other cephalosporins.
    Zamboni C; Fava C; Fera MT; Focà A
    Boll Ist Sieroter Milan; 1984 Mar; 63(1):37-41. PubMed ID: 6591925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
    Aldridge KE
    Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity of Salmonella species to four "classical" antibiotics and seven new beta-lactamic antibiotics (author's transl)].
    Roy C; Pellicer MT; Segura C; Foz A
    Med Clin (Barc); 1980 Nov; 75(8):327-30. PubMed ID: 6904743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the in vitro activity of cefotetan on bacterial strains of recent hospital isolation].
    Lembo M; Nani E; Covelli I; Anzivino D; Gulletta E
    G Batteriol Virol Immunol; 1985; 78(7-12):224-44. PubMed ID: 3870426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of bacterial pathogens to cefotetan judged by MIC and disc tests.
    Grimm H
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():37-43. PubMed ID: 6573324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of aztreonam and other antimicrobial agents against Salmonella species.
    Paradelis AG; Delidou K; Stavrakis AO; Crassaris LG
    Drugs Exp Clin Res; 1985; 11(3):163-7. PubMed ID: 3836124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
    Daschner FD; Goerke C; Bassler M; Just M
    Chemotherapy; 1982; 28(5):351-4. PubMed ID: 6958416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotetan: comparative study in vitro against 226 Gram-negative clinical isolates.
    Morel C; Vergnaud M; Langeard MM; Dupuy L
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():31-6. PubMed ID: 6573323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compounds.
    Wise R; Andrews JM; Hancox J
    Antimicrob Agents Chemother; 1982 Mar; 21(3):486-91. PubMed ID: 6954875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative susceptibilities of organisms isolated in Sicily to cefotetan and other antibiotics.
    Russo G; Gismondo MR; Toscano MA; Speciale AM; Nicoletti G
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():79-85. PubMed ID: 6573327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of cefotetan and other cephalosporins against multiresistant strains of Enterobacteriaceae.
    Leigh DA; Marriner J
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():103-5. PubMed ID: 6573310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties.
    Kays MB; White RL; Friedrich LV; Del Bene VE
    Clin Ther; 1991; 13(5):596-605. PubMed ID: 1799917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro antibacterial activity of cefotetan.
    Grassi GG; Alesina R; Ferrara A; Peona V
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():45-58. PubMed ID: 6573325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefotetan: antimicrobial activity in-vitro compared with that of cefotaxime.
    Dette GA; Knothe H; Henckel S
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():11-7. PubMed ID: 6302064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in-vitro activity of cefotetan (ICI 156834), a new cephamycin derivative, with that of cefoxitin.
    Chattopadhyay B; Teli JC
    J Antimicrob Chemother; 1982 Aug; 10(2):151-4. PubMed ID: 6956565
    [No Abstract]   [Full Text] [Related]  

  • 16. In-vitro activity of cefotetan, other beta-lactams and netilmicin.
    Shah PM
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():73-8. PubMed ID: 6573326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in-vitro activity of cefotetan against Serratia spp. and Enterobacter spp. in comparison with other cephalosporins.
    Campello C; Stradoni R; Majori L
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():87-93. PubMed ID: 6573328
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sensitivity in vitro of 61 strains of Salmonella to aminoglycoside antibiotics and to cephalosporins].
    Boemi G; Esposito M; Valenti GF
    Ann Sclavo; 1978; 20(5):753-62. PubMed ID: 753138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory activity of cefotetan and other beta-lactams against anaerobes.
    Werner H
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():107-15. PubMed ID: 6573311
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of different statistical methodologies on the evaluation of the in-vitro MICs for Bacteroides fragilis of selected cephalosporins and cephamycins.
    White RL; Kays MB; Friedrich LV; Del Bene VE
    J Antimicrob Chemother; 1993 Jan; 31(1):57-64. PubMed ID: 8444675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.